Celgene’s Budding Blockbuster Abraxane Scoops Pancreatic Cancer Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Abraxane sales have been growing fast as Celgene has added new indications. Pancreatic cancer had been an off-label use prior to the new approval.